Blood-brain barrier permeable anticholinesterase aurones: synthesis, structure-activity relationship, and drug-like properties

European Journal of Medicinal Chemistry
Kok-Fui LiewChong-Yew Lee

Abstract

A series of novel aurones bearing amine and carbamate functionalities at various positions (rings A and/or B) of the scaffold was synthesized and evaluated for their acetylcholinesterase and butyrylcholinesterase inhibitory activities. Structure-activity relationship study disclosed several potent submicromolar acetylcholinesterase inhibitors (AChEIs) particularly aurones bearing piperidine and pyrrolidine moieties at ring A or ring B. Bulky groups particularly methoxyls, and carbamate to a lesser extent, at either rings were also prominently featured in these AChEI aurones as exemplified by the trimethoxyaurone 4-3. The active aurones exhibited a lower butyrylcholinesterase inhibition. A 3'-chloroaurone 6-3 originally designed to improve the metabolic stability of the scaffold was the most potent of the series. Molecular docking simulations showed these AChEI aurones to adopt favourable binding modes within the active site gorge of the Torpedo californica AChE (TcAChE) including an unusual chlorine-π interaction by the chlorine of 6-3 to establish additional bondings to hydrophobic residues of TcAChE. Evaluation of the potent aurones for their blood-brain barrier (BBB) permeability and metabolic stability using PAMPA-BBB assay...Continue Reading

References

Feb 13, 2001·Plant Science : an International Journal of Experimental Plant Biology·T SatoT Kusumi
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
Jun 27, 2003·Current Opinion in Chemical Biology·Li Di, Edward H Kerns
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Jan 8, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuBill J Smith
May 5, 2004·Journal of Pharmaceutical Sciences·Li DiDonna M Huryn
Jan 22, 2005·Journal of Medicinal Chemistry·Michela RosiniCarlo Melchiorre
Jan 6, 2006·Journal of Medicinal Chemistry·Sabrina OkombiAhcène Boumendjel
Aug 19, 2007·Current Topics in Medicinal Chemistry·Andrea Regier Voth, P Shing Ho
Apr 25, 2008·Protein Science : a Publication of the Protein Society·Yumi N ImaiKazuo Kitaura
Dec 17, 2008·Bioconjugate Chemistry·Yoshifumi MayaMorio Nakayama
Apr 11, 2009·Journal of Medicinal Chemistry·Yunxiang LuWeiliang Zhu
Jun 26, 2009·BMC Neurology·William A Banks
Feb 9, 2010·Cellular & Molecular Biology Letters·Ana FariaConceição Calhau
May 1, 2010·Nature Reviews. Drug Discovery·Martin Citron
Mar 12, 2011·Neuroscience and Biobehavioral Reviews·Laura A CraigRobert J McDonald
Jul 5, 2011·Bioorganic & Medicinal Chemistry Letters·Seo Young ShinYong Sup Lee
Nov 1, 2011·British Journal of Clinical Pharmacology·Salvatore SalomoneFilippo Drago
Nov 5, 2011·Current Medicinal Chemistry·M BajdaB Malawska
May 29, 2012·Bioorganic & Medicinal Chemistry Letters·Fan-Chao MengXing-Shu Li
Aug 30, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·William M Pardridge
Dec 12, 2012·Protein Science : a Publication of the Protein Society·Matthew R ScholfieldP Shing Ho

❮ Previous
Next ❯

Citations

May 27, 2016·ACS Chemical Neuroscience·Laurent LunvenSabine Chierici
Dec 4, 2020·Bioorganic & Medicinal Chemistry·Guoqing SuiWenming Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.